Tag: Continuous Glucose Monitor (CGM)
DME providers can help physicians manage diabetes population, study finds
March 21, 2025Theresa Flaherty, Managing Editor
DALLAS – The No. 1 reason physicians cite for not prescribing a continuous glucose monitor is its complexity, a roadblock that DME providers can help clear, according to a new study from CCS.
That complexity, along with a surge in the number of diabetes patients, leaves primary care physicians and endocrinologists feeling overwhelmed and not able to keep up-to-date on technology, and, ultimately, struggling to offer enough health coaching and education to their patients. That creates...
Sequel Med Tech collaborates with Abbott
March 19, 2025HME News Staff
MANCHESTER, N.H. – Sequel Med Tech has announced that Abbott’s FreeStyle Libre 3 Plus sensor will be the first continuous glucose monitoring device to work with its twiist Automated Insulin Delivery (AID) System powered by Tidepool. The sensor will be compatible with twiist when the system is expected to launch in the second quarter of 2025. “We are thrilled to announce our collaboration with Abbott, integrating its world-leading FreeStyle Libre technology as our first CGM partner,...
Henry Schein makes advance in ‘particularly attractive’ CGM market
March 14, 2025Theresa Flaherty, Managing Editor
MELVILLE, N.Y. – The combination of Henry Schein’s distribution capabilities with Acentus’ technology expertise will pack a one-two punch as they position themselves for future growth in the competitive diabetes market, the companies say.
Henry Schein closed recently on its acquisition of the Tampa, Fla.-based Acentus, a national supplier specializing in CGMs, in a deal that broadened its portfolio of home medical supply products.
“Acentus really enhances and integrates...
Trinity Biotech zeroes in on CGM
March 13, 2025HME News Staff
DUBLIN – Trinity Biotech, a commercial-stage biotech company focused on human diagnostics and diabetes management solutions, including wearable biosensors, has appointed Barclays Capital as its exclusive financial advisor to support its ongoing strategic realignment, including its increased focus on continuous glucose monitoring technology. As part of this effort, Barclays is now actively assessing how the company’s existing businesses can best align with this new strategic direction....
Senseonics, Ascensia hit sweet spot
March 3, 2025HME News Staff
PARSIPPANY, N.J. – Senseonics Holdings and Ascensia Diabetes Care have integrated SweetSpot with the Eversense 365 Continuous Glucose Monitoring (CGM) System in the U.S., providing endocrinology practices that partner with them the ability to continue to improve patient care by seamlessly and regularly reviewing data from patients. SweetSpot combines a centralized software platform for managing diabetes device data with wrap-around clinical support services, including a virtual team...
CCS study: Physicians ‘overwhelmed’ by soaring diabetes numbers
February 26, 2025HME News Staff
DALLAS – The vast majority of physicians caring for people with diabetes say they are overwhelmed, according to a new study from CCS, a provider of clinical solutions and home medical supplies for those living with chronic conditions.
Eighty-five percent of endocrinologists and 58% of PCPs feel overwhelmed by the number of patients with diabetes, demonstrating that many are not in a position to properly support the ongoing education and coaching needs of people living with diabetes,...
CGM bill aims to preserve two-channel option
February 14, 2025Theresa Flaherty, Managing Editor
LITTLE ROCK, Ark. – A new bill in Arkansas is the first on a state level to try and stem the “migration” of coverage for continuous glucose monitors to a pharmacy-only benefit.
Introduced Jan. 27, HB1255 would amend existing Medicaid coverage of CGMs to allow beneficiaries to obtain CGMs through the DME benefit and would allow DME providers to bill for the devices using a HCPCS code rather than the national drug code number used by pharmacies.
“We don't...
Senseonics files for CE Mark
February 13, 2025HME News Staff
GERMANTOWN, Md. – Senseonics Holdings has filed for CE Mark registration for the Eversense 365 CGM system, paving the way for commercialization in European Union countries by Acensia Diabetes Care. “Completing the CE Mark submission for Eversense 365 brings us a step closer to improving lives and health outcomes for patients in Europe,” said Tim Goodnow, president and CEO of Senseonics. “Given the success we have had to date with the U.S. launch, we look forward to the opportunity...
Glucotrack completes first human clinical study for CBGM
February 7, 2025HME News Staff
RUTHERFORD, N.J. — Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein. CBGMs offer the potential for direct measurement without the limitations often seen with traditional continuous glucose monitors measuring glucose levels in interstitial fluid. “We are thrilled with the results of this first in-human clinical study, which establishes safety of the placement, usage and...
Cardinal Health teases upside from ADSG acquisition
January 31, 2025Liz Beaulieu, Editor
DUBLIN, Ohio – Cardinal Health’s acquisition of Advanced Diabetes Supply Group hasn’t closed yet, but company officials said on a conference call to discuss second quarter financial results that they’re “looking forward to talking about the profit contributions from that business in future quarters.”
Cardinal Health announced in November that it had entered into a definitive agreement to acquire ADSG, which serves about 500,000 patients annually with a...